Aristo Bio-Tech & Lifescience Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹4 Cr
QMarch 2025
Quarterly Results

In 2026, Aristo Bio-Tech & Lifescience (ARISTO) reported revenue ₹0 Cr and net profit ₹0 Cr. Also explore ARISTO share price data to track price trends across different timeframes.

ARISTO Quarterly Results — Revenue, Profit & EPS Highlights

Aristo Bio-Tech & Lifescience latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit ARISTO stock price BSE.

  • Revenue of ₹319 Cr in March 2025 (+0.0% vs March 2025, +30.2% vs March 2024)
  • Net Profit of ₹4 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹10 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 3.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹5.97 in March 2025 (+0.0% vs March 2025)

Aristo Bio-Tech & Lifescience Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ARISTO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 0 319 245 218 166 - -
Net Profit (₹ Cr) 0 4 4 4 1 - -
EBITDA (₹ Cr) 0 10 9 9 5 - -
EPS (₹) 0.00 5.97 5.72 6.72 2.87 - -
Operating Margin (%) 0.0% 3.0% 3.0% 4.0% 3.0% - -

ARISTO Share Price Trend — 1-Year Movement Across Quarterly Results

Aristo Bio-Tech & Lifescience 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with ARISTO fair value to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin 1.3%
EBITDA Margin 3.1%
Operating Margin 3.0%
ROE (Annual) 10.8%

Balance Sheet Highlights

Total Assets ₹141 Cr
Total Equity ₹37 Cr
Current Assets ₹116 Cr
Current Liabilities ₹8 Cr

Cash Flow Analysis

Operating Cash Flow ₹10 Cr
Investing Cash Flow ₹-5 Cr
Financing Cash Flow ₹-4 Cr
Net Cash Flow ₹1 Cr

ARISTO vs Chemicals Peers — Quarterly Revenue, Profit & Market Cap

Aristo Bio-Tech & Lifescience latest quarter revenue and net profit vs Chemicals competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Pidilite Industries
Mar 2026
₹150,700.65 Cr 1480.7 3,648 584 +1.2% +13.2% 16.0% 260.2
SRF
Mar 2026
₹81,125.55 Cr 2736.8 4,557 582 +28.0% +7.2% 12.8% 139.4
Linde
Sept 2025
₹61,592.27 Cr 7259.0 650 171 +7.4% - 26.3% 362.0
Fertilisers & Chemi…
Sept 2025
₹58,928.84 Cr 923.4 1,681 21 +48.8% - 1.2% 2885.6
UPL
Mar 2026
₹55,390.17 Cr 656.2 18,513 1,294 +49.2% +18.1% 7.0% 52.2
Sector Quarterly Performance Comparison
Chemicals sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores